Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovitrelle vs Pregnyl for oocyte maturation in high responders
NCT00415766Phase 4Unknown
- Sponsor
- Eugonia
- Start
- Jun 2013
- Primary completion
- Dec 2015
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of recombinant human chorionic gonadotrophin in infertility, sponsored by Eugonia. Primary endpoint: Percentage of mature oocytes at Day 0. Status: unknown.
02
Drugs
recombinant human chorionic gonadotrophin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT00415766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415766.